News

Promising results from the Pre-POInT-early study, which investigated the safety and immune effects of high-dose oral insulin immunotherapy in children before the age of 2, when they are most susceptible to d...

The latest feature in our series celebrating Insulin@100 focuses on the potent but precarious synergy of exercise and insulin.

Transplantation conference hears calls for an end to the notion of islet transplantation as experimental therapy, to be dealt with separately from whole pancreas transplantation in national allocation polici...

In lock step with the pandemics of obesity and type 2 diabetes, another, less talked about condition is on the rise: non-alcoholic fatty liver disease (NAFLD).

Links between non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes loomed large at the Paris Hepatology Conference in March, as did the potential use of diabetes treatments to counter the rise of th...

EASD e-Learning’s latest initiative, ‘The long and the short it’, launches today.

Are DCD donors the solution to boosting islet transplantations?

Results from the Coronavirus SARS-CoV-2 and Diabetes Outcomes (CORONADO) study have identified variables linked to hospital discharge or to death among patients with diabetes hospitalised for COVID-19, estab...

That patients should play a central role in managing their condition is now a generally acknowledged truism of diabetes care – at least in theory. What’s less widely spoken of are the many ways i...

The importance of involving patients in their own care and ensuring that their voices are heard was the theme of three presentations within the Patients Inclusion Initiative, a joint EPITA/EDTCO/ETAHP sympos...

A study published last May in the New England Journal of Medicine (NEJM), which described morphological and molecular changes in the lungs of people who died from COVID-19, is now cited as a turning point in...

COVID-19 has had a devastating impact on islet and pancreas transplantation, with many centres suspending their programmes and major reductions in organ retrievals. On day one of the 11th European Pancreas a...

This week the EASD e-Learning platform is launching a new section on its site. Called ‘Horizons’, the section aims to be a more user-friendly central place where our learners can get diabete...

Listening to our learners is at the forefront of ensuring the EASD e-Learning programme is up to date, evidence based and meets the needs of our learners. It is also important that you know your feedback is ...

The deadline for applications is 14th March. It is open to all paid-up members of EASD who have received their highest medical degree no more than 7 years before 1st January 2021.

Should type 2 diabetes medications with proven cardiovascular benefits be used to prevent atherosclerotic cardiovascular disease in type 1 diabetes?

As the obesity pandemic accelerates, the search for a safe, affordable, practicable, minimally invasive solution has become ever more urgent. The need to tackle this crisis has been further highlighted by th...

The association between severe COVID-19 and obesity is well established, but how exactly does obesity fit into the COVID-19 picture?

Coming soon…New EASD e-Learning courses on recent literature around diabetes and COVID-19 as well as on diabetes and metabolic surgery are currently in development and will be launching in 2021.

Coming soon…